DeepIntent Launches Cora, the First Fully Agentic Marketing Platform for Healthcare

Cora represents a major AI breakthrough in how pharmaceutical brands and their agency partners understand markets, collaborate across teams, and activate campaigns across marketing channels

NEW YORK, Sept. 10, 2026 /PRNewswire/ -- As pharmaceutical companies develop increasingly specialized treatments, marketers face a growing challenge: successfully reaching more precisely defined patient populations while navigating increasingly complex and competitive markets. Today, DeepIntent announced DeepIntent Cora™, the first fully agentic marketing platform built specifically for healthcare, designed to fundamentally transform how pharma companies strategize, collaborate and activate omnichannel marketing campaigns.

DeepIntent Cora brings agentic AI to healthcare marketing, enabling marketers to move rapidly from market intelligence to strategy with simple conversational language. Rather than requiring marketers to navigate multiple complex tools, data sets, and disconnected workflows, Cora brings these capabilities together in a single, simple, collaborative environment.

The need for a new approach is becoming increasingly urgent. More than 60% of drug treatments fail to meet their forecasted commercial goals, underscoring the difficulty of developing a clear path to commercial success. As pharma innovation increasingly shifts toward treatments for more specialized patient populations, the ability to identify, understand, and engage the right audiences with greater precision will become even more critical.

From fragmented hand-offs to an agentic marketing workflow

DeepIntent Cora is designed to transform the traditional pharma marketing workflow by bringing intelligence, data and execution together in a simple, agentic interface. Cora's capabilities include:

• Conversational, agentic planning and execution. With Cora, marketers direct purpose-built agents with natural language to interrogate complex healthcare data, develop precise patient and healthcare provider audiences, and move from insight to activation without requiring advanced technical or programmatic expertise. In beta testing, Cora cut marketing planning time cycles by 50% with over 95% of customers reporting drastically faster workflows.
• Omnichannel planning, audience building, and activation. For the first time, healthcare marketers will be able to forecast, plan, and activate audiences across channels within one platform – not just programmatic. New integrations, including VideoAmp for linear TV planning and forecasting, extend Cora's capabilities well beyond a traditional demand-side platform (DSP).
• Real-time AI-driven intelligence. Cora continuously surfaces personalized, actionable insights across campaigns, competitors, clinical developments, market conditions, and media signals – helping to optimize campaigns more rapidly.
• An expanded healthcare marketing cloud. Cora draws on DeepIntent Helix™, the industry's richest and most trusted healthcare marketing cloud. With this launch, Helix expands to incorporate new types of data, including payer and formulary signals, and richer diagnostic data, providing a broader foundation for planning, decision-making, and audience-building.
• Collaborative human-and-AI workspaces. Cora introduces live, project-based workspaces that bring marketers, agencies, and AI agents together around a shared view of planning, activation, and optimization. Teams collaborate across brands and agencies and manage approvals and workflows, eliminating disconnected silos and handoffs.

"For over a decade, DeepIntent has built a platform with a singular focus on healthcare. With Cora, we are expanding beyond programmatic advertising and unlocking the value of agentic AI for strategy, planning, and activation across channels," said Chris Paquette, Founder and CEO, DeepIntent. "Just as drug development becomes more precise, Cora will break down siloes, helping our clients understand markets, collaborate more efficiently, and ultimately engage with patients and providers with unprecedented speed and confidence. In doing so, Cora will help pharma brands and their agencies bring more treatments to market successfully, while improving the quality of life for the patients they serve."

Cora is available today for all DeepIntent clients in an open beta. In a survey of 275 customers in a closed beta earlier this year, 95% reported drastically faster times conducting research, planning, and activating campaigns, with reported reductions of 50% or more in time.

Clients comment on Cora:

EVERSANA INTOUCH

"It takes an incredible amount of time, resources and data to launch a new treatment or therapy into the market. We're constantly looking for solutions that can help maximize our resources and deliver for customers," said Dave Leitner, EVP, Head of Media, EVERSANA INTOUCH. "We've found DeepIntent's Cora platform extremely beneficial in helping provide data- and AI-driven views that enable us to make smarter media investment decisions from day one, a clearer picture of realistic launch outcomes, and a sharper focus on driving maximum return on investment for clients, all measures that we value as a media partner."

Deerfield Group

"Navigating the healthcare ecosystem with disconnected data sets, fragmented channels and measurement tools can be complex. We've seen clients get stuck on connecting insights to action," said Bill Veltre, Chief Media Officer, Deerfield Group. "Our partnership with DeepIntent has enabled our teams to build marketing strategies that create value for our clients' businesses. And now with innovations like Cora, we're taking it further by connecting data to real decisions in a meaningful way. We're excited for what this means for the brands we work with."

Klick Health

"Our team deals with billions of programmatic media impressions every day for our healthcare clients, said Kristy Quagliariello, VP, Programmatic Media, Klick Health. "So being able to easily aggregate and quickly analyze all that data using DeepIntent's Cora agentic platform delivers a lot of value."

About DeepIntent

DeepIntent is the leading healthcare marketing platform, purpose-built to help marketers plan, activate, and optimize data-driven campaigns with speed and precision. Trusted by the world's top healthcare brands and their agencies, DeepIntent uniquely unites media, identity, and real-world clinical data to power privacy-safe, omnichannel marketing across every screen. Backed by patented technology and proven outcomes, DeepIntent's platform delivers measurable audience quality and script lift at scale. Learn more at www.deepintent.com.

Media Contact
Melinda Zurich
DeepIntent
[email protected] 

SOURCE DeepIntent